Nodus Oncology
UK-based biotech company focused on developing molecules that inhibit novel DNA damage response (DDR) targets
Nodus Oncology has raised €2.7M across 1 funding round from 2 investors, most recently a round in Feb 2023. Based in Edinburgh, UK; active in Healthtech. Data as of 28 Oct 2026.
Edinburgh, UKwww.nodusoncology.com ↗
Total raised
€2.7M
€2,686,427
Funding rounds
1
Investors
2
distinct backers
Active since
2023-02
latest 2023-02
Funding by year
EUR raised per yearNodus Oncology — funding by year — interactive chart.
Data table
| Nodus Oncology — funding by year | |
|---|---|
| 2023 | €2.7M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-07 | Other | €2.7M | Cumulus Oncology,KHAN Technology Transfer Fund I | View deal → |
Related news
- Nodus Oncology Raises £2.4M in Fundingfinsmes.com · 2023-02
Similar companies
same sector or countryGlobal coverage: FundingData